用埃斯基塔洛普拉姆降低大脑对情绪刺激的反应,而不是用于抑郁症的 псилоцибин治疗

Matthew B Wall1, Lysia Demetriou1, Bruna Giribaldi1

  • 1Perceptive Inc. (formerly Invicro LLC), Hammersmith Hospital, London (Wall, Demetriou, Ertl); Department of Metabolism, Digestion, and Reproduction (Wall, Ertl) and Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Faculty of Medicine (Wall, Ertl, Giribaldi, Roseman, Erritzoe, Nutt, Carhart-Harris), Imperial College London; Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK (Demetriou); Department of Neurology, University of California, San Francisco (Carhart-Harris).

概括

对抑郁症的 псилоцибин治疗显示出显著的症状改善,但对情绪处理大脑反应的影响很小,与减少情绪反应的SSRI不同. 这表明迷幻疗法可能为治疗抑郁症提供了不同的作用机制.